London Capital Investment Partners's Gainsborough partnership invests in companies quoted on AIM and Plus markets.
London Capital Investment Partners's Gainsborough partnership invests in companies quoted on AIM and Plus markets. The partnership will develop a portfolio of approximately 20 companies. Gainsborough will allocate 20% of its funds to approximately 10 "Earlier Companies" and 80% of its assets to approximately 10 Later Companies. This defensive asset allocation profile will give partners exposure to exciting younger companies, while giving the portfolio a base of more developed companies.To date the partnership has invested in the following companies:* Plastics Capital plc (http://www.plasticscapital.com/)* Surface Transforms plc (http://www.surface-transforms.com/)* Immunodiagnostic Systems Holdings plc (http://www.idsltd.com)* BrainJuicer Group plc (www.brainjuicer.com)* Scancell Holdings plc (www.scancell.co.uk)
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
---|---|---|---|---|
May 1, 2008
OmniGuide
|
Series E | $25M | Health Care | — |
Apr 6, 2004
Continuum Photonics
|
Series C | $17.50M | Manufacturing | — |
Apr 2, 2003
Cetek Corporation
|
Series Unknown | $6M | Biopharma | — |
Oct 12, 2001
Cetek Corporation
|
Series Unknown | $14M | Biopharma | — |
Sep 12, 2000
Continuum Photonics
|
Series A | $1M | Manufacturing | — |
Gainesborough Investment Partners has had 1 exits. Gainesborough Investment Partners most notable exits include Continuum Photonics
Date | Company Name | Exit Type | Industry | |
---|---|---|---|---|
Sep 26, 2005 | Continuum Photonics | M&A | Manufacturing | Detail |